|
211 |
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
Enthalten in Arthritis Research & Therapy Bd. 7, 24.3.2005, Nr. 3, date:3.2005: 1-22
|
|
|
|
212 |
Topical NSAIDs for acute pain: a meta-analysis
Enthalten in BMC family practice Bd. 5, 17.5.2004, Nr. 1, date:12.2004: 1-9
|
|
|
|
213 |
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
Enthalten in BMC musculoskeletal disorders Bd. 5, 19.8.2004, Nr. 1, date:12.2004: 1-8
|
|
|
|
214 |
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study
Enthalten in Trials Bd. 20, 16.4.2019, Nr. 1, date:12.2019: 1-10
|
|
|
|
215 |
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
Enthalten in Arthritis Research & Therapy Bd. 10, 7.2.2008, Nr. 1, date:2.2008: 1-16
|
|
|
|
216 |
Why Do People Become Involved With Archaeology? Some Answers from Alabama’s Black Belt Region
Enthalten in Archaeologies Bd. 7, 31.12.2011, Nr. 3, date:12.2011: 538-553
|
|
Administration
